Lessons learned from clinical phenotypes in early psoriatic arthritis: the real-world Dutch south west Early Psoriatic ARthritis study

References

• Scher JU, Ogdie A, Merola JF, Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol 2019;15:153–66.
   PubMed Web of Science ®Google Scholar
• Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med 2017;376:957–70.
   PubMed Web of Science ®Google Scholar
• Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55–78.
   PubMedGoogle Scholar
• Niccoli L, Nannini C, Cassara E, Kaloudi O, Susini M, Lenzetti I, et al. Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study. Int J Rheum Dis 2012;15:414–8.
   PubMed Web of Science ®Google Scholar
• Lindqvist UR, Alenius GM, Husmark T, Theander E, Holmstrom G, Larsson PT, et al. The Swedish early psoriatic arthritis register – 2-year followup: a comparison with early rheumatoid arthritis. J Rheumatol 2008;35:668–73.
   PubMed Web of Science ®Google Scholar
• Theander E, Husmark T, Alenius GM, Larsson PT, Teleman A, Geijer M, et al. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish early Psoriatic Arthritis register (SwePsA). Ann Rheum Dis 2014;73:407–13.
   PubMed Web of Science ®Google Scholar
• Coates LC, Moverley AR, McParland L, Brown S, Navarro-Coy N, O’Dwyer JL, et al. Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. Lancet 2015;386:2489–98.
   PubMed Web of Science ®Google Scholar
• Blonde L, Khunti K, Harris SB, Meizinger C, Skolnik NS. Interpretation and impact of real-world clinical data for the practicing clinician. Adv Ther 2018;35:1763–74.
   PubMed Web of Science ®Google Scholar
• Kennedy-Martin T, Curtis S, Faries D, Robinson S, Johnston J. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials 2015;16:495.
   PubMed Web of Science ®Google Scholar
• Mease PJ. Measures of psoriatic arthritis: tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthritis Care Res (Hoboken) 2011;63(Suppl 11):S64–85.
   PubMed Web of Science ®Google Scholar
• Fredriksson T, Pettersson U. Severe psoriasis–oral therapy with a new retinoid. Dermatologica 1978;157:238–44.
   PubMedGoogle Scholar
• Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken) 2011;63(Suppl 11):S240–52.
   PubMed Web of Science ®Google Scholar
• Hewlett S, Dures E, Almeida C. Measures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for severity, effect, and coping, Chalder Fatigue Questionnaire (CFQ), Checklist Individual Strength (CIS20R and CIS8R), Fatigue Severity Scale (FSS), Functional Assessment Chronic Illness Therapy (Fatigue) (FACIT-F), Multi-Dimensional Assessment of Fatigue (MAF), Multi-Dimensional Fatigue Inventory (MFI), Pediatric Quality Of Life (PedsQL) Multi-Dimensional Fatigue Scale, Profile of Fatigue (ProF), Short Form 36 Vitality Subscale (SF-36 VT), and Visual Analog Scales (VAS). Arthritis Care Res (Hoboken) 2011;63(Suppl 11):S263–86.
   PubMed Web of Science ®Google Scholar
• Nijsten TE, Sampogna F, Chren MM, Abeni DD. Testing and reducing Skindex-29 using Rasch analysis: Skindex-17. J Invest Dermatol 2006;126:1244–50.
   PubMed Web of Science ®Google Scholar
• Bruce B, Fries JF. The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol 2005;23(Suppl 39):S14–18.
   Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361–70.
   PubMed Web of Science ®Google Scholar
• Snaith RP. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes 2003;1:29.
   PubMedGoogle Scholar
• Leung YY, Ho KW, Zhu TY, Tam LS, Kun EW, Li EK. Testing scaling assumptions, reliability and validity of Medical Outcomes Study Short-Form 36 Health Survey in psoriatic arthritis. Rheumatology (Oxford) 2010;49:1495–501.
   PubMed Web of Science ®Google Scholar
• Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:727–36.
   Web of Science ®Google Scholar
• McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 2004;63:162–9.
   PubMed Web of Science ®Google Scholar
• Wink F, Arends S, McKenna SP, Houtman PM, Brouwer E, Spoorenberg A. Validity and reliability of the Dutch adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire. PLoS One 2013;8:e55912.
   PubMed Web of Science ®Google Scholar
• Bouwmans C, Krol M, Severens H, Koopmanschap M, Brouwer W, Hakkaart-van Roijen L. The iMTA productivity cost questionnaire: a standardized instrument for measuring and valuing health-related productivity losses. Value Health 2015;18:753–8.
   PubMed Web of Science ®Google Scholar
• McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res 2011;45:1027–35.
   PubMed Web of Science ®Google Scholar
• Albert PR. Why is depression more prevalent in women? J Psychiatry Neurosci 2015;40:219–21.
   PubMed Web of Science ®Google Scholar
• Meesters J, Bergman S, Haglund E, Jacobsson L, Petersson IF, Bremander A. Prognostic factors for change in self-reported anxiety and depression in spondyloarthritis patients: data from the population-based SpAScania cohort from southern Sweden. Scand J Rheumatol 2018;47:185–93.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Chandran V. Observational cohort studies: lessons learnt from the University of Toronto psoriatic arthritis program. Rheumatology (Oxford) 2011;50:25–31.
   PubMed Web of Science ®Google Scholar
• Kalyoncu U, Bayindir O, Ferhat Oksuz M, Dogru A, Kimyon G, Tarhan EF, et al. The psoriatic arthritis registry of Turkey: results of a multicentre registry on 1081 patients. Rheumatology (Oxford) 2017;56:279–86.
   PubMed Web of Science ®Google Scholar
• Stekhoven D, Scherer A, Nissen MJ, Grobety V, Yawalkar N, Villiger PM, et al. Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtyping. Clin Rheumatol 2017;36:2035–43.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Karki C, Palmer JB, Etzel CJ, Kavanaugh A, Ritchlin CT, et al. Clinical characteristics, disease activity, and patient-reported outcomes in psoriatic arthritis patients with dactylitis or enthesitis: results from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. Arthritis Care Res (Hoboken) 2017;69:1692–9.
   PubMed Web of Science ®Google Scholar
• Hetland ML. DANBIO: a nationwide registry of biological therapies in Denmark. Clin Exp Rheumatol 2005;23:S205–7.
   PubMed Web of Science ®Google Scholar
• Kvien TK, Heiberg LE, Kaufmann C, Mikkelsen K, Nordvag BY, E Rødevand. A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases. Clin Exp Rheumatol 2005;23(Suppl 39):S188–94.
   Web of Science ®Google Scholar
• Feld J, Chandran V, Gladman DD. What is axial psoriatic arthritis? J Rheumatol 2018;45:1611–13.
   PubMed Web of Science ®Google Scholar
• Mau W, Listing J, Huscher D, Zeidler H, Zink A. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 2005;32:721–8.
   PubMed Web of Science ®Google Scholar
• Gajdos V, Beydon N, Bommenel L, Pellegrino B, de Pontual L, Bailleux S, et al. Inter-observer agreement between physicians, nurses, and respiratory therapists for respiratory clinical evaluation in bronchiolitis. Pediatr Pulmonol 2009;44:754–62.
   PubMed Web of Science ®Google Scholar
• Nossent JC, Gran JT. Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway. Scand J Rheumatol 2009;38:251–5.
   PubMed Web of Science ®Google Scholar
• Helliwell PS, Firth J, Ibrahim GH, Melsom RD, Shah I, Turner DE. Development of an assessment tool for dactylitis in patients with psoriatic arthritis. J Rheumatol 2005;32:1745–50.
   PubMed Web of Science ®Google Scholar